# Rosetta Genomics Ltd.: Form D filings

Rosetta Genomics Ltd., a biotechnology company in Rehovot, Israel, filed 6 Form D notices with the SEC between 2011 and 2012. The latest, on February 9, 2012, reports $1.8 million sold of a $1.8 million offering to 1 investor.

Find out what Rosetta Genomics Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Rosetta%20Genomics%20Ltd.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Rosetta%20Genomics%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Frosetta-genomics-ltd-1362959)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Rosetta%20Genomics%20Ltd.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Rosetta%20Genomics%20Ltd.&page=%2Fdata%2Fform-d%2Fcompany%2Frosetta-genomics-ltd-1362959)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 10 PLAUT STREET, SCIENCE PARK, Rehovot, Israel, 76706
- Phone: 972-73-222-0700
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Israel
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1362959

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 9, 2012 | New notice | $1,750,000 | $1,750,000 | $0 | 1 | Jan 26, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295912000001/0001362959-12-000001-index.htm) |
| Nov 1, 2011 | New notice | $1,948,501 | $1,518,751 | $429,750 | 21 | Oct 19, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295911000006/0001362959-11-000006-index.htm) |
| Mar 7, 2011 | Amendment | $2,725,000 | $2,725,000 | $0 | 13 | Feb 23, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295911000004/0001362959-11-000004-index.htm) |
| Mar 7, 2011 | Amendment | $2,500,000 | $2,500,000 | $0 | 17 | Dec 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295911000003/0001362959-11-000003-index.htm) |
| Mar 3, 2011 | New notice | $2,725,000 | $2,725,000 | $0 | 13 | Feb 23, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295911000002/0001362959-11-000002-index.htm) |
| Mar 3, 2011 | New notice | $2,500,000 | $2,500,000 | $0 | 17 | Dec 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1362959/000136295911000001/0001362959-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Brian Markison | Director |  |
| Ranit Aharonov | Executive Officer |  |
| Joshua Rosensweig | Director |  |
| Tomer Assis | Executive Officer |  |
| Tali Yaron-Eldar | Director |  |
| Kenneth Berlin | Executive Officer |  |
| Gerald Dogon | Director |  |
| David Sidransky | Director |  |
| Oded Biran | Executive Officer |  |

[Every Form D from the week of Feb 6, 2012](https://specstream.ai/data/form-d/week/2012-02-06) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Rosetta Genomics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).